HOPA Partners with other Oncology Leaders to Maintain IV Chemo Resources

MILWAUKEE, WI – September 3, 2021 – The Hematology/Oncology Pharmacy Association (HOPA) collaborated with National Community Oncology Dispensing Association, Inc. (NCODA), Oncology Nursing Society (ONS) and Association of Community Cancer Centers (ACCC) to launch a new Intravenous Cancer Treatment Education (IVE) website, ivcanceredsheets.com.

The website is a joint effort dedicated to forward thinking and to providing thorough education resources to improve treatment outcomes. The IVE website provides healthcare workers the latest education material for intravenous cancer treatments, communicating vital information to help caregivers and those experiencing cancer.

The sheets include common uses and treatment schedules, supportive medications, drug interactions, side effect management and safe handling tips at home following treatment.

Oncology professionals and caregivers can download a number of IVE sheets from the site’s library, which will continue to be updated by the collaborative. The sheets also are editable so pharmacists can customize them to an individual’s treatment plan.

The launch of IV Cancer Treatment Education Sheets online follows the success of the highly utilized OCE (Oral Chemotherapy Education) online resource, which also is a collaborative initiative between NCODA, HOPA, ONS and ACCC. With a committee consisting of representatives from each of the organizations, a development process is structured to produce trusted and reliable education sheets that provide a robust amount of information on individual drugs and combination drug regimens.

The Hematology/Oncology Pharmacy Association (HOPA) supports hematology/oncology pharmacy professionals and promotes the role of the pharmacist in collaborative cancer care. Founded in 2004, HOPA provides crucial education, networking, and advancement opportunities frequently sought by pharmacists, pharmacy interns, residents, fellows, students, technicians, researchers, and administrators who specialize in hematology/oncology pharmacy. Its vision is to ensure that all individuals affected by cancer have a hematology/oncology pharmacist as an integral member of their care team

Tools and Resources

Standardization of IDS Key Performance Indicators and Metrics; Results of a HOPA IDS SIG Survey

The Hematology/Oncology Pharmacy Association has helped establish practical guidance for Investigational Services metrics and site utilization.

X-ray of brain with desmoid tumors
Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Nirogacestat (Ogsiveo)

Brooke Lochridge, PharmD ,PGY-2 Oncology Pharmacy Resident, of Tristar Centennial Medical Center, Nashville, TN, and Colleen McCabe, PharmD, BCOP, Oncology Clinical Specialist, Sarcoma & Melanoma from Vanderbilt University Medical Center, Nashville, TN w

high-risk neuroblastoma
Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Eflornithine for High-Risk Neuroblastoma

Taylor Gullickson, PharmD, PGY1 Pharmacy Resident and Alexis Kuhn, PharmD, BCOP, Pediatric Oncology Pharmacist, from Mayo Clinic Rochester, Minnesota write about Eflornithine for High-Risk Neuroblastoma.